A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.
Acta Neurol Belg
; 118(2): 161-168, 2018 Jun.
Article
en En
| MEDLINE
| ID: mdl-29536270
ABSTRACT
Multiple sclerosis is considered to be an immune mediated inflammatory disorder of the central nervous system. It mainly affects young, socioeconomic active patients. Although our armamentarium for this disease has significantly evolved in recent years some patients remain refractory to conventional therapies. In these cases, autologous hematopoietic stem cell transplantation can be considered as a therapeutic option. Decreasing morbidity, mortality, and increasing patient awareness have led to rising inquiry by our patients about this treatment option. With the aim of a standardized protocol and data registration, a Belgian working party on stem cell therapy in multiple sclerosis was established. In this paper, we report the consensus protocol of this working party on autologous hematopoietic stem cell transplantation in multiple sclerosis.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Trasplante de Células Madre Hematopoyéticas
/
Consenso
/
Esclerosis Múltiple
Tipo de estudio:
Diagnostic_studies
/
Guideline
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Europa
Idioma:
En
Revista:
Acta Neurol Belg
Año:
2018
Tipo del documento:
Article
País de afiliación:
Bélgica